Market Tracker

03/24 5:16pm ET

Gilead Sciences Inc (NASDAQ:GILD)

67.51
Delayed Data
As of Mar 24
 +0.02 / +0.03%
Today’s Change
65.38
Today|||52-Week Range
103.10
-5.73%
Year-to-Date

Today’s Trading

Previous close67.49
Today’s open67.57
Day’s range67.20 - 67.87
Volume6,037,791
Average volume (3 months)10,104,620
Market cap$88.2B
Dividend yield3.08%
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-28.03%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-5.37%
P/E ratio6.8
Price/Sales3.21
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-0.59-0.21%
AMGNAmgen-0.30-0.18%
ILMNIllumina Inc+2.89+1.72%
BIVVBioverativ Inc-0.17-0.34%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.26
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts